Northwestern University Human Resources

Northwestern University Human Resources logo
🇺🇸United States
Ownership
Private
Established
1851-01-28
Employees
5K
Market Cap
-
Website
https://www.venturecat.northwestern.edu

High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy

Phase 2
Terminated
Conditions
First Posted Date
2005-08-19
Last Posted Date
2012-06-11
Lead Sponsor
Northwestern University
Target Recruit Count
1
Registration Number
NCT00131924
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

Make Better Choices Study

First Posted Date
2005-06-10
Last Posted Date
2013-04-04
Lead Sponsor
Northwestern University
Target Recruit Count
204
Registration Number
NCT00113672
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Autoimmunity and Coronary Artery Disease - Ancillary to CARDIA

First Posted Date
2005-03-25
Last Posted Date
2015-03-19
Lead Sponsor
Northwestern University
Target Recruit Count
3020
Registration Number
NCT00106483

Improving Functioning in Peripheral Arterial Disease

First Posted Date
2005-03-23
Last Posted Date
2012-07-25
Lead Sponsor
Northwestern University
Target Recruit Count
156
Registration Number
NCT00106327
Locations
🇺🇸

Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Phase 2
Completed
Conditions
First Posted Date
2004-09-16
Last Posted Date
2012-06-12
Lead Sponsor
Northwestern University
Registration Number
NCT00004172
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors

First Posted Date
2004-08-30
Last Posted Date
2013-07-10
Lead Sponsor
Northwestern University
Registration Number
NCT00004090
Locations
🇺🇸

Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer

Phase 2
Completed
Conditions
First Posted Date
2004-08-30
Last Posted Date
2012-06-06
Lead Sponsor
Northwestern University
Registration Number
NCT00004915
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome

Phase 2
Completed
Conditions
First Posted Date
2004-08-23
Last Posted Date
2012-05-30
Lead Sponsor
Northwestern University
Registration Number
NCT00002479
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer

Phase 2
Completed
Conditions
First Posted Date
2004-08-20
Last Posted Date
2012-06-06
Lead Sponsor
Northwestern University
Registration Number
NCT00004182
Locations
🇺🇸

Stanford University Medical Center, Stanford, California, United States

🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Phase 1
Completed
Conditions
First Posted Date
2004-08-05
Last Posted Date
2012-06-06
Lead Sponsor
Northwestern University
Registration Number
NCT00004096
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath